NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 14 min ago

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Clinical Trial Optional)

Mon, 2023-04-03 05:27
Funding Opportunity RFA-NS-24-022 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRC). The overarching goal of this initiative is to establish a network of Centers that will work collaboratively to define the cause(s) of and discover improved treatments for ME/CFS. A more immediate goal for each Center is to rapidly advance synergistic, interdisciplinary research programs while serving as local resources and national leaders in ME/CFS research. Successful CRC research programs will facilitate research in ME/CFS through conducting of 1) collaborative basic and/or clinical research on ME/CFS; 2) longitudinal studies of individuals with ME/CFS within each ME/CFS CRC and across CRCs within the network; 3) access to information related to ME/CFS for basic and clinical researchers, academic and practicing physicians, healthcare professionals, patients, and the lay public. Clinical data and biospecimen sharing are required, and data management for efficient data collection and data sharing, as well as biospecimen sharing will be addressed through the separate data management and coordinating center (DMCC). Institutions must be committed to the establishment and continuation of the proposed ME/CFS CRC. Funding decisions will focus on those applications most likely to make highly impactful contributions to ME/CFS research, as well as on those with the greatest potential to collaborate effectively across the ME/CFS CRC program.

NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)

Mon, 2023-04-03 05:26
Funding Opportunity PAR-23-162 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) will support, through the cooperative agreement mechanism, investigator-initiated observational studies or biomarker validation studies that require prospective collection of data/biospecimens or continued analysis of data/biospecimens.

Implementing and Evaluating New Models for Delivering Comprehensive, Coordinated, Person-Centered Care to People with Long COVID (U18)

Mon, 2023-04-03 04:20
Funding Opportunity RFA-HS-23-012 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to expand access to comprehensive, coordinated, and person-centered care for people with Long COVID, particularly underserved, rural, vulnerable, or minority populations that are disproportionately impacted by the effects of Long COVID. This NOFO will fund up to nine multidisciplinary Long COVID clinics to (1) develop and implement new or improved care delivery models, (2) provide services to more people with Long COVID, (3) expand services offered, (4) strengthen care coordination, (5) implement and share best practices for Long COVID management, (6) support the primary care community in Long COVID education and management, (7) evaluate project success, and (8) disseminate project findings

Revising the NIH/AHRQ/NIOSH Post-Submission Material Policy

Fri, 2023-03-31 10:09
Notice NOT-OD-23-106 from the NIH Guide for Grants and Contracts

Developing Measures to Advance Access and Quality in Global Mental Health Services (R34 Clinical Trial Not Allowed)

Fri, 2023-03-31 04:34
Funding Opportunity RFA-MH-23-300 from the NIH Guide for Grants and Contracts. This initiative aims to address the gaps in our knowledge about the data, barriers, facilitators, and strategies to advance universal mental health coverage in LMICs. As NIMH continues to support the development, adaptation, and testing of interventions across the globe, it is vital to expand the knowledge-based to inform the adoption and scaling of these evidence-based interventions. This FoA supports innovative experimental and non-experimental research to improve the understanding of critical supply- and demand-side elements needed to augment the access and utilization of mental health services in these settings.

BRAIN Initiative: Brain Behavior Quantification and Synchronization Data Coordination and Artificial Intelligence Center (U24 Clinical Trial Optional)

Fri, 2023-03-31 04:17
Funding Opportunity RFA-MH-23-130 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applications for creating the Data Coordination and Artificial Intelligence Center (DCAIC) for the Brain Behavior Quantification and Synchronization (BBQS) Consortium of the BRAIN Initiative. The FOA will support a single award to a multi-disciplinary team with a single or multiple PIs working on the five interrelated areas:1) Data Management; 2) Data Standards; 3) ML/AI Resources; 4) Data Ecosystem; and 5) Dissemination, Training and Coordination.

BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)

Fri, 2023-03-31 04:10
Funding Opportunity RFA-MH-23-110 from the NIH Guide for Grants and Contracts. The purpose of the The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative Fellows (F32) program is to enhance the research training of promising postdoctorates, early in their postdoctoral training period, who have the potential to become productive investigators in research areas that will advance the goals of the BRAIN Initiative. Applications are encouraged in any research area that is aligned with the BRAIN Initiative, including neuroethics. Applicants are expected to propose research training in an area that clearly complements their predoctoral research. Formal training in analytical tools appropriate for the proposed research is expected to be an integral component of the research training plan. In order to maximize the training potential of the F32 award, this program encourages applications from individuals who have not yet completed their terminal doctoral degree and who expect to do so within 12 months of the application due date. On the application due date, candidates may not have completed more than 12 months of postdoctoral training.

Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)

Thu, 2023-03-30 13:45
Funding Opportunity PAR-23-148 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support applications for epidemiological and observational research projects on the long-term cardiopulmonary sequelae following treatment for tuberculosis (TB). Investigators should propose additional testing and data collection in existing cohorts of adult and/or pediatric TB participants to better characterize and understand adverse outcomes and morbidity associated with TB disease post treatment in individuals with and without HIV infection.

Notice of Special Interest (NOSI): Administrative Supplement for Collaborative Projects Supported by the NIAID RNCP and CCRP

Thu, 2023-03-30 13:38
Notice NOT-AI-23-037 from the NIH Guide for Grants and Contracts

Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional)

Thu, 2023-03-30 04:17
Funding Opportunity RFA-CA-23-023 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to establish collaborations between liver cancer investigators and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-funded Liver Cirrhosis Network (LCN) members to advance our understanding of hepatocellular carcinoma (HCC) as the result of liver cirrhosis and its etiologic risks, development, progression, early diagnosis, and treatment. The funds available through this FOA will support new multidisciplinary liver cancer-specific collaborations between eligible liver cancer investigators and one or more of the NIDDK-funded LCN members. This structure is intended to maximize the effectiveness of the network by facilitating collaborative opportunities that enhance the scientific goals of the collaborating units and the LCN as a whole. Applicants selected for NCI funding will become members of the Liver Cirrhosis Network-Liver Cancer Collaboratory (LCN-LCa) Committee.

Request for Applications (RFA): Revision Applications to Support Research on Prevention and Cessation of Menthol Cigarette Use in Populations that Experience Health Disparities (R01, Clinical Trial Optional)

Thu, 2023-03-30 03:52
Funding Opportunity RFA-OD-23-015 from the NIH Guide for Grants and Contracts. As part of the ADVANCE: Advancing Prevention Research for Health Equity program, the NIH Office of Disease Prevention (ODP) within the Office of the Director Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) is soliciting revision applications (formerly called "competitive revisions") to active R01 grants to support studies that develop and evaluate menthol cigarette smoking cessation and prevention interventions for populations that experience health disparities.

Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional)

Thu, 2023-03-30 03:40
Funding Opportunity PAR-23-152 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement, the National Cancer Institute (NCI) intends to focus on the impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)

Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)

Thu, 2023-03-30 03:40
Funding Opportunity PAR-23-153 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement, the National Cancer Institute (NCI) intends to focus on the impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)

NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)

Tue, 2023-03-28 13:23
Funding Opportunity PAR-23-132 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support research that addresses research questions relevant to human dental, oral, or craniofacial (DOC) diseases and conditions through analysis of existing and publicly available genomics data using data science approaches.

NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)

Tue, 2023-03-28 13:23
Funding Opportunity PAR-23-133 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support research that addresses research questions relevant to human dental, oral, or craniofacial (DOC) diseases and conditions through analysis of existing and publicly available genomics data using data science approaches.

Pages